Abstract:Silencing of dopamine transporter (DAT), a main controlling factor of dopaminergic signaling, results in biochemical and behavioral features characteristic for neuropsychiatric diseases with presumed hyperdopaminergia including schizophrenia, attention deficit hyperactivity disorder (ADHD), bipolar disorder, and obsessive-compulsive disorder (OCD). Investigation of DAT silencing thus provides a transdiagnostic approach towards a systems-level understanding of common underlying pathways. Using a high-field multimodal imaging approach and a highly sensitive cryogenic coil, we integrated structural, functional and metabolic investigations in tandem with behavioral assessments on a newly developed preclinical rat model, comparing DAT homozygous knockout (DAT-KO, N = 14), heterozygous knockout (N = 8) and wild-type male rats (N = 14). We identified spatially distributed structural and functional brain alterations encompassing motor, limbic and associative loops that demonstrated strong behavioral relevance and were highly consistent across imaging modalities. DAT-KO rats manifested pronounced volume loss in the dorsal striatum, negatively correlating with cerebellar volume increase. These alterations were associated with hyperlocomotion, repetitive behavior and loss of efficient functional small-world organization. Further, prefrontal and midbrain regions manifested opposite changes in functional connectivity and local network topology. These prefrontal disturbances were corroborated by elevated myo-inositol levels and increased volume. To conclude, our imaging genetics approach provides multimodal evidence for prefrontal-midbrain decoupling and striato-cerebellar neuroplastic compensation as two key features of constitutive DAT blockade, proposing them as transdiagnostic mechanisms of hyperdopaminergia. Thus, our study connects developmental DAT blockade to systems-level brain changes, underlying impaired action inhibition control and resulting in motor hyperactivity and compulsive-like features relevant for ADHD, schizophrenia and OCD.

Continuous Performance Test Impairment in a 22q11.2 Microdeletion Mouse Model: Improvement by Amphetamine.

Assessing the Cognitive Translational Potential of a Mouse Model of the 22q11.2 Microdeletion Syndrome.

Reviewer #2 (public Review): Adolescent Neurostimulation of Dopamine Circuit Reverses Genetic Deficits in Frontal Cortex Function

Time-on-task-related decrements in performance in the rodent continuous performance test are not caused by physical disengagement from the task

Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice

Profiling attention and cognition enhancing drugs in a rat touchscreen-based continuous performance test

A Mouse Model of the 15q13.3 Microdeletion Syndrome Shows Prefrontal Neurophysiological Dysfunctions and Attentional Impairment

Cognition- and circuit-based dysfunction in a mouse model of 22q11.2 microdeletion syndrome: effects of stress

The Continuous Performance Test (rcpt) for Mice: a Novel Operant Touchscreen Test of Attentional Function.

Development of a novel rodent rapid serial visual presentation task reveals dissociable effects of stimulant versus nonstimulant treatments on attentional processes

MAM-E17 Rat Model Impairments on a Novel Continuous Performance Task: Effects of Potential Cognitive Enhancing Drugs

Cognitive Sequelae of Intravenous Amphetamine Self-Administration in Rats: Evidence for Selective Effects on Attentional Performance

Amphetamine Modestly Improves Conners’ Continuous Performance Test Performance in Healthy Adults

The Effects of D-Amphetamine, Alpha-Flupenthixol, and Mesolimbic Dopamine Depletion on a Test of Attentional Switching in the Rat

D-Amphetamine Remediates Attentional Performance in Rats with Dorsal Prefrontal Lesions

A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission

Lack of Cdk5 activity is involved on Dopamine Transporter expression and function: Evidences from an animal model of Attention-Deficit Hyperactivity Disorder

Dopamine transporter silencing in the rat: systems-level alterations in striato-cerebellar and prefrontal-midbrain circuits

Adolescent neurostimulation of dopamine circuit reverses genetic deficits in frontal cortex function

Histological Analysis of a Mouse Model of the 22q11.2 Microdeletion Syndrome

An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome